Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Point-of-Care Testing
2012 Standout
Thromboembolic prophylaxis in total hip replacement: A comparison between the low molecular weight heparinoid Lomoparan and heparindihydroergotamine
1992
Blood Management
2007
Prudent Strategies for Elective Red Blood Cell Transfusion
1992
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Thromboembolic Disease Prophylaxis in Patients With Hip Fracture
2005
Desmopressin for minimising perioperative allogeneic blood transfusion
1998
EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERY
1987
Ischemic stroke and intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction: A risk-benefit analysis
1992
Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass
1995
The Dose-Response Relationship of Tranexamic Acid
1995
Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Hip-Fracture Surgery
2001
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Comparison of blood reinfusion techniques used during coronary artery bypass grafting
1993
Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting
1990
Effects of Aprotinin on Hemostatic Mechanisms during Cardiopulmonary Bypass
1987
High-dose aprotinin in cardiac surgery: Three years' experience in 1,784 patients
1992
Aprotinin in primary valve replacement and reconstruction: A multicenter, double-blind, placebo-controlled trial
1996
Drugs to Minimize Perioperative Blood Loss in Cardiac Surgery
1997
Tranexamic acid reduces blood loss and transfusion in reoperative cardiac surgery
1997
Prevention of VTE in Orthopedic Surgery Patients
2012 Standout
Tranexamic acid significantly reduces blood loss associated with coronary revascularization
1995
Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention
2004
Perioperative Management of Antithrombotic Therapy
2012 Standout
Tranexamic acid reduces postbypass blood use: A double-blinded, prospective, randomized study of 210 patients
1996
Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass
1993
Patients With Severe Aortic Valve Stenosis and Impaired Platelet Function Benefit From Preoperative Desmopressin Infusion
2011
Antithrombotic Therapy for VTE Disease
2016 Standout
A review of transfusion risks and optimal management of perioperative bleeding with cardiac surgery
2008
A Double-Blind, Placebo-Controlled Trial of Epsilon-Aminocaproic Acid for Reducing Blood Loss in Coronary Artery Bypass Grafting Surgery
2005
Renal effects of high dose desmopressin and dextran. A study in normal subjects and in patients undergoing total hip replacement
1993
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
1992 Standout
Inflammatory response to cardiopulmonary bypass
1993 Standout
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2008 Standout
Hemostatic Drugs
1998
Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines
2006 Standout
Tranexamic Acid
1999 Standout
Transfusion Medicine — Blood Transfusion
1999 Standout
Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis
2005
Relationship of platelet aggregation to bleeding after cardiopulmonary bypass
1994
Prevention of VTE in Nonsurgical Patients
2012 Standout
Thromboprophylaxis with 60 mg Enoxaparin Is Safe in Hip Trauma Surgery
2001
The stress response to trauma and surgery
2000 Standout
Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations
1996
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints
1999
Antithrombotic Therapy for VTE Disease
2012 Standout
Decreased postoperative drainage with addition of ϵ-aminocaproic acid before cardiopulmonary bypass
1994
A Study of the Effectiveness of Two Group Behavioral Medicine Interventions for Patients with Psychosomatic Complaints
1990
A pump-prime aprotinin dose in cardiac surgery: Appraisal of its effects on the hemostatic system
1997
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
2011 Standout
Heparin-Induced Thrombocytopenia
2006 Standout
The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement
2001
A Prospective Study of Venous Thromboembolism after Major Trauma
1994 Standout
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
The CRIT Study: Anemia and blood transfusion in the critically ill—Current clinical practice in the United States*
2004 Standout
PROPHYLAXIS OF DEEP VENOUS THROMBOSIS AND PULMONARY EMBOLISM
1998
Prevention of Venous Thromboembolism
2004 Standout
A Point-of-Care Assessment of the Effects of Desmopressin on Impaired Platelet Function Using Multiple Electrode Whole-Blood Aggregometry in Patients After Cardiac Surgery
2010
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
1995 Standout
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
A Comparison of Danaparoid and Warfarin for Prophylaxis Against Deep Vein Thrombosis After Total Hip Replacement
1998
Adverse effects of methods for minimizing perioperative allogeneic transfusion: A critical review of the literature
1998
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Prevention of Venous Thromboembolism
2008 Standout
Mindfulness-based stress reduction and health benefits
2004 Standout
Incidence of Deep-Vein Thrombosis in Patients with Fractures of the Lower Extremity Distal to the Hip
1996
Reduction of Blood Loss and Transfusion Requirements After Coronary Artery Bypass Grafting:.
1999
A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
1997 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Transfusion Medicine
2001
The stratification of cardiac surgical procedures according to use of blood products: a retrospective analysis of 1480 cases
1991
Platelet-Rich Plasma: A Review of Biology and Applications in Plastic Surgery
2006 Standout
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
1999 Standout
Transfusion and surgery
1993
Does tranexamic acid reduce desmopressin-induced hyperfibrinolysis?
2002
Hemorrhagic Complications of Anticoagulant Treatment
2001 Standout
Prevention of venous thromboembolism in orthopedic surgery with vitamin K antagonists: a meta‐analysis
2004
Red cell transfusions in total knee and total hip replacement surgery
1991
Prevention and Treatment of Major Blood Loss
2007
Effect of tranexamic acid on platelet ADP during extracorporeal circulation
1991
An Analysis of Blood Management in Patients Having a Total Hip or Knee Arthroplasty*
1999 Standout
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
2011 Standout
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
2016 Standout
Tranexamic acid (Cyklokapron) is not necessary to reduce blood loss after coronary artery bypass operations
1993
Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
1994 Standout
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
On the Prophylactic and Therapeutic Use of Danaparoid Sodium (Orgaran®) in Patients With Heparin-Induced Thrombocytopenia
2003
Management of bleeding following major trauma: an updated European guideline
2010
Prevention of Venous Thromboembolism
1992
Effect of aprotinin (Trasylol) on aorta-coronary bypass graft patency
1993
Drugs to Minimize Perioperative Blood Loss in Cardiac Surgery
1997
Factor V Leiden (G1691A) and Prothrombin Gene G20210A Mutations as Potential Risk Factors for Venous Thromboembolism after Total Hip or Total Knee Replacement Surgery
2002 StandoutNobel
Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled study
1992
Pathophysiology and Treatment of Coagulopathy in Massive Hemorrhage and Hemodilution
2010
Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement
1993
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol)
1989
The use of the area under the ROC curve in the evaluation of machine learning algorithms
1997 Standout
Platelet-rich plasma reduces postoperative blood loss after cardiopulmonary bypass
1990
Prophylactic tranexamic acid decreases bleeding after cardiac operations
1990
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Platelet-Rich Plasma
2009 Standout
The hemostatic effect of transfusing fresh whole blood versus platelet concentrates after cardiac operations
1988
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
Aprotinin protects platelets against the initial effect of cardiopulmonary bypass
1990
Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery.
1994
Low-Molecular-Weight Heparins
1997 Standout
A Multicenter, Double-Blind, Placebo-Controlled Trial of Aprotinin for Reducing Blood Loss and the Requirement for Donor-Blood Transfusion in Patients Undergoing Repeat Coronary Artery Bypass Grafting
1995
Desmopressin use for minimising perioperative allogeneic blood transfusion
2004
The role of epsilon-aminocaproic acid in reducing bleeding after cardiac operation: A double-blind randomized study
1988
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial
2010 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Desmopressin use for minimising perioperative blood transfusion
2017
Use of desmopressin and erythropoietin in an anaemic Jehovah’s Witness patient with severely impaired coagulation capacity undergoing stentless aortic valve replacement
2001
Low-Molecular-Weight Heparinoid Orgaran Is More Effective Than Aspirin in the Prevention of Venous Thromboembolism After Surgery for Hip Fracture
1996
Desmopressin Reduces Transfusion Needs after Surgery
2008
Pulmonary Vasodilator Responses to Nitroprusside and Nitroglycerin in the Dog
1981 StandoutNobel
Effects of simulated extracorporeal circulation on human leukocyte elastase release, superoxide generation, and procoagulant activity
1991
Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery.
1991
Diazoxide in treatment of primary pulmonary hypertension.
1978
Works of Michael Smith being referenced
Low-molecular-weight heparinoid compared with warfarin for prophylaxis of deep-vein thrombosis in patients who are operated on for fracture of the hip. A prospective, randomized trial.
1991
Treatment with Desmopressin Acetate to Reduce Blood Loss after Cardiac Surgery
1986
Diazoxide blood levels in man
1967